CDMO News
MGC and HSS Partner to Enter Nucleic Acid Drug CDMO Sector
Mitsubishi Gas Chemical Company has entered a business collaboration with Hokkaido System Science Co. to study the feasibility of developing a nucleic acid drug Contract Development and Manufacturing Organisation (CDMO) business. This partnership is part of MGC’s medium-term management plan,
15 July 2024
Stay ahead of trends and best practices
